bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses

Archive ouverte

Jézéquel, Pascal | Gouraud, Wilfried | Ben Azzouz, Fadoua | Guérin-Charbonnel, Catherine | Juin, Philippe | Lasla, Hamza | Campone, Mario

Edité par CCSD ; Oxford University Press -

International audience. Breast cancer gene-expression miner' (bc-GenExMiner) is a breast cancer-associated web portal (http://bcgenex.ico.unicancer.fr). Here, we describe the development of a new statistical mining module, which permits several differential gene expression analyses, i.e. 'Expression' module. Sixty-two breast cancer cohorts and one healthy breast cohort with their corresponding clinicopathological information are included in bc-GenExMiner v4.5 version. Analyses are based on microarray or RNAseq transcriptomic data. Thirtynine differential gene expression analyses, grouped into 13 categories, according to clinicopathological and molecular characteristics ('Targeted' and 'Exhaustive') and gene expression ('Customized'), have been developed. Output results are visualized in four forms of plots. This new statistical mining module offers, among other things, the possibility to compare gene expression in healthy (cancer-free), tumour-adjacent and tumour tissues at once and in three triple-negative breast cancer subtypes (i.e. C1: molecular apocrine tumours; C2: basal-like tumours infiltrated by immune suppressive cells and C3: basal-like tumours triggering an ineffective immune response). Several validation tests showed that bioinformatics process did not alter the pathobiological information contained in the source data. In this work, we developed and demonstrated that bc-GenExMiner 'Expression' module can be used for exploratory and validation purposes.

Suggestions

Du même auteur

Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches

Archive ouverte | Ben Azzouz, Fadoua | CCSD

International audience. Triple-negative breast cancer (TNBC) heterogeneity represents one of the main obstacles to precision medicine for this disease. Recent concordant transcriptomics studies have shown that TNBC ...

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response

Archive ouverte | Jézéquel, Pascal | CCSD

International audience. INTRODUCTION: Triple-negative breast cancers need to be refined in order to identify therapeutic subgroups of patients.METHODS: We conducted an unsupervised analysis of microarray gene-expres...

iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors

Archive ouverte | Jézéquel, Pascal | CCSD

International audience. Heterogeneity and lack of targeted therapies represent the two main impediments to precision treatment of triple-negative breast cancer (TNBC). Therefore, molecular subtyping and identificati...

Chargement des enrichissements...